Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

Schulenburg, A; Watkins-Riedel, T; Greinix, HT; Rabitsch, W; Loidolt, H; Keil, F; Mitterbauer, M; Kalhs, P.
CMV monitoring after peripheral blood stem cell and bone marrow transplantation by pp65 antigen and quantitative PCR.
Bone Marrow Transplant. 2001; 28(8):765-768 Doi: 10.1038/sj.bmt.1703227 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Co-Autor*innen der Med Uni Graz
Greinix Hildegard
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
We prospectively monitored 74 consecutive allogeneic and 50 autologous patients after bone marrow/stem cell transplantation from May 1999 to October 2000 at our institution with quantitative CMV PCR and pp65 antigen assay once weekly from conditioning therapy to days 120 and 80 after transplantation, respectively. Written informed consent was obtained from every patient. CMV prophylaxis consisted of acyclovir during transplant. Additionally all patients received only platelet products from CMV-negative donors. In the case of CMV infection preemptive therapy with gancyclovir was applied. In the case of CMV disease high-dose immunoglobulin was given as well. In the allogeneic setting 16 out of 74 (22%) patients developed a positive PCR. Seven episodes of a positive pp65 antigen assay occurred in six allograft recipients. In the autologous setting no positive assay was found during the whole observation period. Additionally, in 6/16 patients a lymphoproliferative assay was performed during CMV infection. Two patients showed a positive (15 and 5.4) and four a negative (2,1.6,1,1.8) stimulation index.
Find related publications in this database (using NLM MeSH Indexing)
Adolescent -
Adult -
Antigens, Viral - blood
Antiviral Agents - therapeutic use
Biological Markers -
Bone Marrow Transplantation - mortality
Cytomegalovirus - isolation & purification
Cytomegalovirus Infections - blood Cytomegalovirus Infections - diagnosis Cytomegalovirus Infections - drug therapy Cytomegalovirus Infections - etiology Cytomegalovirus Infections - mortality Cytomegalovirus Infections - prevention & control
DNA, Viral - blood
Female -
Ganciclovir - therapeutic use
Hematopoietic Stem Cell Transplantation - mortality
Humans -
Immunocompromised Host -
Lymphocyte Count -
Male -
Middle Aged -
Phosphoproteins - blood
Polymerase Chain Reaction - methods
Survival Rate -
Transplantation, Autologous -
Transplantation, Homologous -
Treatment Outcome -
Viral Matrix Proteins - blood
Viremia - blood Viremia - diagnosis Viremia - etiology

Find related publications in this database (Keywords)
CMV
pp65
quantitative PCR
transplantation
© Med Uni Graz Impressum